XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Aug. 31, 2022
Aug. 31, 2021
Aug. 31, 2020
Revenue      
Revenue $ 325,660 $ 293,336 $ 261,162
Costs and Expenses      
Cost of products and services sold 202,708 174,660 161,615
Selling, general and administrative expenses 54,438 52,100 49,364
Research and product development costs 4,415 4,056 4,007
Operations optimization costs (Note 20) 842 977 807
Acquisition-related costs (Note 14) 4,000 128 274
Gain on sale of real estate (Note 19)     (2,551)
Write-down of certain assets under construction (Note 20)   100 405
Loss on impairment of goodwill (Note 4) 0    
Loss on contingent consideration (Note 14) 432 1,664  
Operating income 58,825 59,651 47,241
Interest expense (425) (297) (246)
Other income (expense) 198 (760) (1,675)
Income before income taxes 58,598 58,594 45,320
Income taxes (Note 7) 13,927 13,674 11,163
Net income $ 44,671 $ 44,920 $ 34,157
Net income available to common shareholders, per common and common equivalent share (Note 17)      
Basic $ 4.72 $ 4.75 $ 3.62
Diluted $ 4.70 $ 4.73 $ 3.59
Weighted average shares outstanding      
Basic 9,399,085 9,383,085 9,359,940
Diluted 9,434,341 9,428,416 9,439,750
Annual cash dividends declared per share $ 1.00 $ 0.80 $ 0.80
Sales      
Revenue      
Revenue $ 322,462 $ 289,802 $ 257,742
Royalties and commissions      
Revenue      
Revenue $ 3,198 $ 3,534 $ 3,420